MedTrace Logo

CLEAR Procedure in Myopia and Astigmatism - Registry Study

NCT05484531 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2022-08-02

No results posted yet for this study

Summary

Multicenter, prospective, single-arm, observational, non-interventional post market clinical investigation (registry study) with the overall objective to assess safety and performance of CLEAR in a real world setting.

Conditions

  • Myopia
  • Astigmatism

Interventions

DEVICE

CLEAR

Reduction or elimination of myopia from -0.50 D to -10.00 D, with astigmatism of 0 D to -5.00 D or without astigmatism, and MRSE of -0.50 D to -12.50 D in the eye to be treated in patients who are 18 years of age or older with documentation of stable manifest refraction over the past year as demonstrated by a change in sphere and cylinder of ≤ 0.50 D in magnitude

Sponsors & Collaborators

  • Ziemer Ophthalmic Systems AG

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-31
Primary Completion
2024-04-30
Completion
2024-04-30
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05484531 on ClinicalTrials.gov